K
Market Data
$12.55+$1.25 (+11.06%)
KROS · Last trade
Prev Close
$11.30
Range (30d)
$10.61 – $12.55
Recent Filings
- 8-K238.6 KBKeros Therapeutics, Inc.Mar 9, 8:01 AM ET·0001664710-26-000024
- 8-K4.6 MBKeros Therapeutics, Inc.Mar 4, 4:08 PM ET·0001664710-26-000021
- 10-K13.5 MBKeros Therapeutics, Inc.Mar 4, 4:04 PM ET·0001664710-26-000018
- 8-K319.3 KBKeros Therapeutics, Inc.Mar 4, 4:02 PM ET·0001664710-26-000017
- 8-K232.9 KBKeros Therapeutics, Inc.Feb 26, 4:02 PM ET·0001664710-26-000008
- 8-K215.2 KBKeros Therapeutics, Inc.Feb 18, 4:02 PM ET·0001664710-26-000005
- 8-K4.5 MBKeros Therapeutics, Inc.Jan 9, 4:16 PM ET·0001664710-26-000003
- 10-Q6.0 MBKeros Therapeutics, Inc.Nov 5, 4:05 PM ET·0001664710-25-000089
- 8-K287.5 KBKeros Therapeutics, Inc.Nov 5, 4:02 PM ET·0001664710-25-000086
- 8-K532.7 KBKeros Therapeutics, Inc.Oct 15, 6:40 AM ET·0001104659-25-099512
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Arkin Bio Ventures Limited Partnership10% Owner
- Arkin Moshe10% Owner
- BIENAIME JEAN JACQUESDirector
- Cho EstherChief Legal Officer
- CHYUNG YUNG H.Chief Medical Officer
- Cooper Simon PeterChief Medical Officer
- Farzan NimaDirector
- GORDON CARL LDirector
Tickers
Addresses
business
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
mailing
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421